Dorian Therapeutics
Organization Description
Dorian Therapeutics is a company developing senoblockers, a new class of therapeutics that can rejuvenate cells and tissues. Based on a patented technology developed at Stanford University, Dorian’s team is bringing to the clinic an innovative solution for age-associated diseases.
As of March 2024 the Dorian Therapeutics website no longer functions and we conclude that the company has ceased operations.
Team
